Media-OutReach Newswire ESR Delivers Stellar Growth with EBITDA and Net Profit up 42.9% and 20.8% to US$549.1 Million and US$245.2 Million, Respectively
HKBU-led research develops novel drug delivery system for Gouteng compound for Alzheimer’s disease treatment 1.